食管鳞癌组织中nm23-H1和E-cadherin的表达及临床意义
The Expression and Clinical Significance of nm23-H1 and E-Cadherin in Esophageal Squamous Cell Carcinomas
DOI: 10.12677/ACM.2016.64027, PDF, HTML, XML, 下载: 1,716  浏览: 2,961 
作者: 廖谦和, 毛 飞, 徐 丹:沭阳人民医院病理科,江苏 沭阳
关键词: 食管鳞状细胞癌nm23-H1E-cadherin免疫组织化学Esophageal Squamous Cell Carcinomas nm23-H1 E-Cadherin Immunohistochemistry
摘要: 目的:研究转移抑制基因(nm23-H1)和E-钙粘附蛋白(E-cadherin)在食管鳞癌组织中表达情况,了解两者之间的相关性及其与临床病理特征的关系。方法:采用免疫组化EnVision法检测60例食管鳞癌组织中nm23-H1和E-cadherin的表达情况,比较其相关性。结果:食管鳞癌组织中nm23-H1和E-cadherin的阳性表达率分别为38.3% (23/60)和41.7% (25/60),正常食管黏膜组织中nm23-H1和E-cadherin的阳性表达均为90.0% (9/10),nm23-H1和E-cadherin在食管鳞癌组织中的阳性表达率显著低于正常食管黏膜组织。nm23-H1、E-cadherin表达与食管癌患者的年龄、性别、组织类型无关(P > 0.05),而与肿瘤分化程度、浸润深度、区域淋巴结转移及TNM分期有关(P < 0.05)。nm23-H1和E-cadherin在食管鳞癌组织中的表达呈显著正相关。结论:nm23-H1和E-cadherin在食管鳞癌中的表达均为低表达,并明显低于正常食管粘膜。nm23-H1和E-cadherin的异常表达与肿瘤分化程度、浸润深度、淋巴结转移及临床分期关系密切,nm23-H1和E-cadherin可以作为判定食管鳞癌恶性程度及转移等生物学行为的参考指标。
Abstract: Objective: The objective is to investigate the expressions of nm23-H1 and E-cadherin in esophageal squamous cell carcinomas, and to explore the correlation between the two and its relationship with clinical pathological features. Methods: The expressions of nm23-H1 and E-cadherin in the tumor tissues of 60 patients with esophageal squamous cell carcinomas were examined immuno-histochemistrically by the EnVision method, and their relationships were compared. Results: The positive rates of nm23-H1 and E-cadherin in expression in the esophageal squamous cell car-cinomas tissue were 38.3% (23/60) and 41.7% (25/60), respectively. The positive rates of nm23-H1 and E-cadherin in expression in the normal esophageal mucosa were 90.0% (9/10). The positive expression rates of nm23-H1 and E-cadherin in esophageal squamous cell carcinomas were significantly lower than those in normal esophageal mucosa. The expression of nm23-H1 and E-cadherin had no significant correlation with the patients’ age, sex, histological type (P > O.05), but had correlation with degree of the differentiation, depth of tumor invasion, regional lymph node metastasis and TNM stage (P < 0.05). Nm23-H1 had positive correlation with E-cadherin. Conclusions: The expression of nm23-H1 and E-cadherin in esophageal squamous cell carcinomas was obviously lower than that in normal esophageal mucosa. The abnormal expression of nm23-H1 and E-cadherin are closely related to the degree of the differentiation of the cancer, depth of tumor invasion, lymph node metastasis and clinical stage; nm23-H1 and E-cadherin may be used as reference for assessing the malignancy and metastasis of esophageal squamous cell carcinomas.
文章引用:廖谦和, 毛飞, 徐丹. 食管鳞癌组织中nm23-H1和E-cadherin的表达及临床意义[J]. 临床医学进展, 2016, 6(4): 151-155. http://dx.doi.org/10.12677/ACM.2016.64027

参考文献

[1] Zhang, Y., Luo, X., Fan, B., et al. (2015) Effect of CO2 Pneumoperitoneum on the Proliferation Human Ovarian Cancer Cell Line SKOV-3 and the Expression of NM23-H1 and MMP-2. Archives of Gynecology and Obstetrics, 291, 403-411.
http://dx.doi.org/10.1007/s00404-014-3414-2
[2] Cao, X.J., Hao, J.F., Yang, X.H., et al. (2012) Prognostic Value of Expres-sion of EGFR and nm23 for Locoregionally Advanced Nasopharyngeal Carcinoma. Medical Oncology, 29, 263-271.
http://dx.doi.org/10.1007/s12032-010-9782-y
[3] Edge, S.B., Byrd, D.R., Comoton, C.C., et al. (2009) AJCC Cancer Staging Manual. 7th Edition, Springer, New York.
[4] Lovato, A., Marioni, G., Manzato, E., et al. (2015) Elderly Patients at Higher Risk of Laryngeal Carcinoma Recurrence Could Be Identified by a Panel of Two Biomarkers (nm23-H1 and CD105) and pN+ Status. Euro-pean Archives of Oto-Rhino-Laryngology, 272, 3417-3424.
http://dx.doi.org/10.1007/s00405-014-3310-1
[5] 张明伟, 王芳, 张雷, 等. 基因nm23-H1和TGFβ1在人体食管癌中的表达及其临床病理关系的意义[J]. 临床和实验医学杂志, 2008, 7(8): 43-44.
[6] 马杰, 李宝生, 闫婧, 等. 食管癌组织中E-cadherin的表达及其与临床病理特征和预后关系的研究[J]. 中华肿瘤防治杂志, 2008, 15(1): 31-34.
[7] 邸永辉, 苗杰. 食管组织中Cx43和E-cad的表达及其相关性分析[J]. 临床与实验病理学杂志, 2015, 31(10): 1099- 1100.
[8] Tang, B., Peng, Z.H., Yu, P.W., et al. (2011) Expression and Significance of Cx43 and E-Cadherin in Gastric Carcer and Metastatic Lymph Nodes. Medical Oncology, 28, 502-508.
http://dx.doi.org/10.1007/s12032-010-9492-5